Sunbelt Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $788K | Sell |
12,988
-325
| -2% | -$18.9K | 0.05% | 305 |
|
|
2025
Q4 | $718K | Buy |
13,313
+878
| +7% | +$42.2K | 0.05% | 319 |
|
|
2025
Q3 | $561K | Sell |
12,435
-7,651
| -38% | -$357K | 0.04% | 359 |
|
|
2025
Q2 | $1.14M | Buy |
20,086
+9,467
| +89% | +$465K | 0.1% | 186 |
|
|
2025
Q1 | $648K | Sell |
10,619
-9,467
| -47% | -$552K | 0.06% | 269 |
|
|
2024
Q4 | $1.13M | Sell |
20,086
-30
| -0.1% | -$1.68K | 0.1% | 187 |
|
|
2024
Q3 | $1.04M | Buy |
20,116
+1,173
| +6% | +$55K | 0.1% | 195 |
|
|
2024
Q2 | $787K | Buy |
18,943
+8,863
| +88% | +$397K | 0.08% | 229 |
|
|
2024
Q1 | $547K | Buy |
10,080
+1,614
| +19% | +$82.2K | 0.06% | 305 |
|
|
2023
Q4 | $434K | Buy |
8,466
+1,631
| +24% | +$85.6K | 0.05% | 336 |
|
|
2023
Q3 | $397K | Buy |
6,835
+42
| +0.6% | +$2.57K | 0.05% | 339 |
|
|
2023
Q2 | $434K | Buy |
6,793
+595
| +10% | +$39.9K | 0.06% | 310 |
|
|
2023
Q1 | $423K | Buy |
6,198
+38
| +0.6% | +$2.68K | 0.07% | 280 |
|
|
2022
Q4 | $443K | Buy |
6,160
+606
| +11% | +$45.7K | 0.09% | 268 |
|
|
2022
Q3 | $395K | Buy |
5,554
+3
| +0.1% | +$218 | 0.08% | 277 |
|
|
2022
Q2 | $427K | Buy |
5,551
+7
| +0.1% | +$533 | 0.09% | 267 |
|
|
2022
Q1 | $409K | Sell |
5,544
-1,781
| -24% | -$120K | 0.07% | 293 |
|
|
2021
Q4 | $483K | Buy |
7,325
+457
| +7% | +$26.8K | 0.08% | 275 |
|
|
2021
Q3 | $462K | Hold |
6,868
| – | – | 0.08% | 264 |
|
|
2021
Q2 | $462K | Sell |
6,868
-78
| -1% | -$5.09K | 0.08% | 264 |
|
|
2021
Q1 | $439K | Buy |
6,946
+493
| +8% | +$30.7K | 0.09% | 263 |
|
|
2020
Q4 | $400K | Buy |
6,453
+1,397
| +28% | +$85.9K | 0.08% | 265 |
|
|
2020
Q3 | $305K | Sell |
5,056
-967
| -16% | -$58.2K | 0.08% | 253 |
|
|
2020
Q2 | $354K | Buy |
6,023
+803
| +15% | +$48K | 0.12% | 204 |
|
|
2020
Q1 | $291K | Sell |
5,220
-33,457
| -87% | -$2.04M | 0.01% | 308 |
|
|
2019
Q4 | $2.48M | Sell |
38,677
-1,014
| -3% | -$58.1K | 0.26% | 92 |
|
|
2019
Q3 | $2.01M | Buy |
39,691
+33,861
| +581% | +$1.59M | 0.23% | 102 |
|
|
2019
Q2 | $264K | Buy |
5,830
+246
| +4% | +$11.5K | 0.11% | 218 |
|
|
2019
Q1 | $266K | Buy |
5,584
+125
| +2% | +$6.23K | 0.13% | 187 |
|
|
2018
Q4 | $284K | Buy |
5,459
+236
| +5% | +$12.7K | 0.17% | 162 |
|
|
2018
Q3 | $324K | Buy |
5,223
+666
| +15% | +$39.5K | 0.17% | 157 |
|
|
2018
Q2 | $252K | Sell |
4,557
-986
| -18% | -$53.3K | 0.15% | 182 |
|
|
2018
Q1 | $351K | Sell |
5,543
-19
| -0.3% | -$1.22K | 0.32% | 104 |
|
|
2017
Q4 | $341K | Buy |
5,562
+55
| +1% | +$3.44K | 0.33% | 108 |
|
|
2017
Q3 | $351K | Buy |
5,507
+920
| +20% | +$53.7K | 0.37% | 95 |
|
|
2017
Q2 | $256K | Buy |
4,587
+4
| +0.1% | +$218 | 0.48% | 65 |
|
|
2017
Q1 | $249K | Buy |
4,583
+4
| +0.1% | +$219 | 0.37% | 73 |
|
|
2016
Q4 | $268K | Buy |
4,579
+4
| +0.1% | +$219 | 0.41% | 65 |
|
|
2016
Q3 | $247K | Buy |
4,575
+3
| +0.1% | +$193 | 0.3% | 77 |
|
|
2016
Q2 | $336K | Buy |
4,572
+2
| +0% | +$141 | 0.44% | 52 |
|
|
2016
Q1 | $292K | Buy |
4,570
+3
| +0.1% | +$189 | 0.43% | 57 |
|
|
2015
Q4 | $314K | Buy |
4,567
+3
| +0.1% | +$198 | 0.44% | 50 |
|
|
2015
Q3 | $270K | Buy |
4,564
+3
| +0.1% | +$190 | 0.37% | 71 |
|
|
2015
Q2 | $303K | Buy |
4,561
+3
| +0.1% | +$198 | 0.42% | 58 |
|
|
2015
Q1 | $294K | Sell |
4,558
-997
| -18% | -$62.4K | 0.44% | 51 |
|
|
2014
Q4 | $328K | Buy |
+5,555
| New | +$313K | 0.43% | 52 |
|
Other funds holding BMY
VCM
VPM
Sunbelt Securities's BMY Position: Q1 2026 in Review
Sunbelt Securities reduced its Bristol-Myers Squibb (BMY) stake by 2.4% in Q1 2026, selling an estimated $18.9K and leaving 12,988 shares worth $788K. The position accounts for 0.05% of the portfolio, ranked #305.
Sunbelt Securities first reported a position in BMY in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.48M in Q4 2019. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Sunbelt Securities held 12,988 shares of Bristol-Myers Squibb worth $788K as of Q1 2026.
- Sunbelt Securities sold 325 Bristol-Myers Squibb shares in Q1 2026, an estimated $18.9K.
- Bristol-Myers Squibb made up 0.05% of Sunbelt Securities's portfolio in Q1 2026, its #305 holding.
- Sunbelt Securities first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 46 quarters since.
- Sunbelt Securities's Bristol-Myers Squibb position peaked at $2.48M in Q4 2019.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.